{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:56:08Z","timestamp":1791240968296,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Foundation for Young Scientists of China","award":["No.82402228"],"award-info":[{"award-number":["No.82402228"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0531100,2024ZD0531101"],"award-info":[{"award-number":["2024ZD0531100,2024ZD0531101"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82272088"],"award-info":[{"award-number":["No.82272088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82271941, 82471947"],"award-info":[{"award-number":["No. 82271941, 82471947"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82472051"],"award-info":[{"award-number":["No.82472051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Municipal Science and Technology Planning Project","award":["No.2025A04J4774"],"award-info":[{"award-number":["No.2025A04J4774"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"DOI":"10.1038\/s41523-026-00991-4","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:56:18Z","timestamp":1781733378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting early-stage breast cancer disease-free survival and adjuvant therapy benefit from multimodal information using deep learning"],"prefix":"10.1038","volume":"12","author":[{"given":"Yifan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"991_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA 75, 10\u201345 (2025).","journal-title":"CA"},{"key":"991_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41571-024-00891-1","volume":"21","author":"E Hoffmann","year":"2024","unstructured":"Hoffmann, E. et al. Multiparametric MRI for characterization of the tumour microenvironment. Nat. Rev. Clin. Oncol. 21, 428\u2013448 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"991_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jamaoncol.2023.4837","volume":"10","author":"JD Benitez Fuentes","year":"2024","unstructured":"Benitez Fuentes, J. D. et al. Global stage distribution of breast cancer at diagnosis. JAMA Oncol. 10, 71\u201378 (2024).","journal-title":"JAMA Oncol."},{"key":"991_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jamaoncol.2019.4794","volume":"6","author":"JA Sparano","year":"2020","unstructured":"Sparano, J. A. et al. Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: A secondary analysis of the TAILORx randomized clinical trial. JAMA Oncol. 6, 367\u2013374 (2020).","journal-title":"JAMA Oncol."},{"key":"991_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(23)00285-4","volume":"401","author":"J Braybrooke","year":"2023","unstructured":"Braybrooke, J. et al. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials. Lancet 401, 1277\u20131292 (2023).","journal-title":"Lancet"},{"key":"991_CR6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan, H. et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N. Engl. J. Med. 377, 1836\u20131846 (2017).","journal-title":"N. Engl. J. Med."},{"key":"991_CR7","doi-asserted-by":"publisher","first-page":"e0284460","DOI":"10.1371\/journal.pone.0284460","volume":"18","author":"Y Lee","year":"2023","unstructured":"Lee, Y. et al. Survival outcomes of breast cancer patients with recurrence after surgery according to period and subtype. PLoS ONE 18, e0284460 (2023).","journal-title":"PLoS ONE"},{"key":"991_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804710","author":"JA Sparano","year":"2018","unstructured":"Sparano, J. A. et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1804710 (2018).","journal-title":"N. Engl. J. Med."},{"key":"991_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso, F. et al. 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N. Engl. J. Med. 375, 717\u2013729 (2016).","journal-title":"N. Engl. J. Med."},{"key":"991_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","volume":"34","author":"G Curigliano","year":"2023","unstructured":"Curigliano, G. et al. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann. Oncol. 34, 970\u2013986 (2023).","journal-title":"Ann. Oncol."},{"key":"991_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","volume":"35","author":"S Loibl","year":"2024","unstructured":"Loibl, S. et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 35, 159\u2013182 (2024).","journal-title":"Ann. Oncol."},{"key":"991_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 9, 465\u2013472 (2023).","journal-title":"JAMA Oncol."},{"key":"991_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10549-016-4051-1","volume":"161","author":"RA Freedman","year":"2017","unstructured":"Freedman, R. A. et al. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on modern cooperative group trials (alliance A151511). Breast Cancer Res. Treat. 161, 363\u2013373 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"991_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s42256-024-00807-9","volume":"6","author":"S Pai","year":"2024","unstructured":"Pai, S. et al. Foundation model for cancer imaging biomarkers. Nat. Mach. Intell. 6, 354\u2013367 (2024).","journal-title":"Nat. Mach. Intell."},{"key":"991_CR15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222841","volume":"308","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Assessing quantitative parenchymal features at baseline dynamic contrast-enhanced MRI and cancer occurrence in women with extremely dense breasts. Radiology 308, e222841 (2023).","journal-title":"Radiology"},{"key":"991_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1148\/radiol.2020192039","volume":"295","author":"JY Kim","year":"2020","unstructured":"Kim, J. Y. et al. Kinetic heterogeneity of breast cancer determined using computer-aided diagnosis of preoperative MRI scans: relationship to distant metastasis-free survival. Radiology 295, 517\u2013526 (2020).","journal-title":"Radiology"},{"key":"991_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1148\/radiol.2019181706","volume":"291","author":"JY Kim","year":"2019","unstructured":"Kim, J. Y., Kim, J. J., Hwangbo, L., Kang, T. & Park, H. Diffusion-weighted imaging of invasive breast cancer: relationship to distant metastasis-free survival. Radiology 291, 300\u2013307 (2019).","journal-title":"Radiology"},{"key":"991_CR18","doi-asserted-by":"crossref","unstructured":"Wiegertjes, K. et al. Diffusion-weighted imaging lesions and risk of recurrent stroke after intracerebral haemorrhage. J. Neurol. Neurosurg. Psychiatry 92, 950\u2013955 (2021).","DOI":"10.1136\/jnnp-2021-326116"},{"key":"991_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1148\/radiol.10102057","volume":"259","author":"C Iacconi","year":"2011","unstructured":"Iacconi, C. & Giannelli, M. Can diffusion-weighted MR imaging be used as a biomarker for predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer?. Radiology 259, 303\u2013304 (2011).","journal-title":"Radiology"},{"key":"991_CR20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232508","author":"N P\u00f6tsch","year":"2024","unstructured":"P\u00f6tsch, N., Sodano, C. & Baltzer, P. A. T. Performance of diffusion-weighted imaging\u2013based noncontrast MRI protocols for diagnosis of breast cancer: a systematic review and meta-analysis. Radiology https:\/\/doi.org\/10.1148\/radiol.232508 (2024).","journal-title":"Radiology"},{"key":"991_CR21","doi-asserted-by":"publisher","first-page":"14288","DOI":"10.1109\/TNNLS.2023.3277633","volume":"35","author":"D Kumar","year":"2024","unstructured":"Kumar, D. & Maji, P. Discriminative deep canonical correlation analysis for multi-view data. IEEE Trans. Neural Netw. Learn. Syst. 35, 14288\u201314300 (2024).","journal-title":"IEEE Trans. Neural Netw. Learn. Syst."},{"key":"991_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s42256-023-00633-5","volume":"5","author":"S Steyaert","year":"2023","unstructured":"Steyaert, S. et al. Multimodal data fusion for cancer biomarker discovery with deep learning. Nat. Mach. Intell. 5, 351\u2013362 (2023).","journal-title":"Nat. Mach. Intell."},{"key":"991_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.112953","volume":"191","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information. Eur. J. Cancer 191, 112953 (2023).","journal-title":"Eur. J. Cancer"},{"key":"991_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ccell.2022.09.012","volume":"40","author":"J Lipkova","year":"2022","unstructured":"Lipkova, J. et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell 40, 1095\u20131110 (2022).","journal-title":"Cancer Cell"},{"key":"991_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clbc.2024.01.005","volume":"24","author":"J Han","year":"2024","unstructured":"Han, J. et al. Prediction of disease-free survival in breast cancer using deep learning with ultrasound and mammography: a multicenter study. Clin. Breast Cancer 24, 215\u2013226 (2024).","journal-title":"Clin. Breast Cancer"},{"key":"991_CR26","doi-asserted-by":"publisher","first-page":"bbac432","DOI":"10.1093\/bib\/bbac432","volume":"23","author":"S Miao","year":"2022","unstructured":"Miao, S. et al. Deep learning radiomics under multimodality explore association between muscle\/fat and metastasis and survival in breast cancer patients. Brief. Bioinf. 23, bbac432 (2022).","journal-title":"Brief. Bioinf."},{"key":"991_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu1521","volume":"11","author":"Z Mo","year":"2025","unstructured":"Mo, Z. et al. Multiomic integration reveals subtype-specific predictors of neoadjuvant treatment response in breast cancer. Sci. Adv. 11, eadu1521 (2025).","journal-title":"Sci. Adv."},{"key":"991_CR28","doi-asserted-by":"publisher","first-page":"9568","DOI":"10.1109\/TNNLS.2022.3160407","volume":"34","author":"Q Lyu","year":"2023","unstructured":"Lyu, Q. & Fu, X. Finite-sample analysis of deep CCA-based unsupervised post-nonlinear multimodal learning. IEEE Trans. Neural Netw. Learn. Syst. 34, 9568\u20139574 (2023).","journal-title":"IEEE Trans. Neural Netw. Learn. Syst."},{"key":"991_CR29","unstructured":"Andrew, G., Arora, R., Bilmes, J. A. & Livescu, K. Deep canonical correlation analysis. In Proc. 30th International Conference on International Conference on Machine Learning. 1247\u20131255 (ICML, 2013)."},{"key":"991_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/jnci\/djab222","volume":"114","author":"ES Villodre","year":"2022","unstructured":"Villodre, E. S. et al. NDRG1 in aggressive breast cancer progression and brain metastasis. J. Natl. Cancer Inst. 114, 579\u2013591 (2022).","journal-title":"J. Natl. Cancer Inst."},{"key":"991_CR31","doi-asserted-by":"publisher","first-page":"101924","DOI":"10.1016\/j.xcrm.2024.101924","volume":"6","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Multimodal integration using a machine learning approach facilitates risk stratification in HR+\/HER2- breast cancer. Cell Rep. Med. 6, 101924 (2025).","journal-title":"Cell Rep. Med."},{"key":"991_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00917-6","volume":"9","author":"N Nikolaou","year":"2025","unstructured":"Nikolaou, N. et al. A machine learning approach for multimodal data fusion for survival prediction in cancer patients. npj Precis. Oncol. 9, 128 (2025).","journal-title":"npj Precis. Oncol."},{"key":"991_CR33","doi-asserted-by":"publisher","first-page":"107765","DOI":"10.1016\/j.phrs.2025.107765","volume":"216","author":"Y Yu","year":"2025","unstructured":"Yu, Y. et al. MRI-based multimodal AI model enables prediction of recurrence risk and adjuvant therapy in breast cancer. Pharmacol. Res. 216, 107765 (2025).","journal-title":"Pharmacol. Res."},{"key":"991_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1550","volume":"14","author":"Q Yang","year":"2024","unstructured":"Yang, Q. et al. Image-guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake. Clin. Transl. Med. 14, e1550 (2024).","journal-title":"Clin. Transl. Med."},{"key":"991_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05843-y","volume":"22","author":"S Gong","year":"2024","unstructured":"Gong, S. et al. Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of triple negative breast cancer. J. Transl. Med. 22, 1016 (2024).","journal-title":"J. Transl. Med."},{"key":"991_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00930-x","volume":"13","author":"OB Poirion","year":"2021","unstructured":"Poirion, O. B., Jing, Z., Chaudhary, K., Huang, S. & Garmire, L. X. DeepProg: An ensemble of deep-learning and machine-learning models for prognosis prediction using multi-omics data. Genome Med. 13, 112 (2021).","journal-title":"Genome Med."},{"key":"991_CR37","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41571-022-00687-1","volume":"19","author":"E Agostinetto","year":"2022","unstructured":"Agostinetto, E., Gligorov, J. & Piccart, M. Systemic therapy for early-stage breast cancer: learning from the past to build the future. Nat. Rev. Clin. Oncol. 19, 763\u2013774 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"991_CR38","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","volume":"32","author":"HJ Burstein","year":"2021","unstructured":"Burstein, H. J. et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann. Oncol. 32, 1216\u20131235 (2021).","journal-title":"Ann. Oncol."},{"key":"991_CR39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1470-2045(21)00007-3","volume":"22","author":"M Piccart","year":"2021","unstructured":"Piccart, M. et al. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age. Lancet Oncol. 22, 476\u2013488 (2021).","journal-title":"Lancet Oncol."},{"key":"991_CR40","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","volume":"385","author":"K Kalinsky","year":"2021","unstructured":"Kalinsky, K. et al. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N. Engl. J. Med. 385, 2336\u20132347 (2021).","journal-title":"N. Engl. J. Med."},{"key":"991_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41591-018-0307-0","volume":"25","author":"J He","year":"2019","unstructured":"He, J. et al. The practical implementation of artificial intelligence technologies in medicine. Nat. Med. 25, 30\u201336 (2019).","journal-title":"Nat. Med."},{"key":"991_CR42","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/annonc\/mdp062","volume":"20","author":"BK Linderholm","year":"2009","unstructured":"Linderholm, B. K. et al. Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. Ann. Oncol. 20, 1639\u20131646 (2009).","journal-title":"Ann. Oncol."},{"key":"991_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10238-024-01446-5","volume":"24","author":"G Elayat","year":"2024","unstructured":"Elayat, G. & Selim, A. Angiogenesis in breast cancer: insights and innovations. Clin. Exp. Med. 24, 178 (2024).","journal-title":"Clin. Exp. Med."},{"key":"991_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07092-9","volume":"15","author":"R Bongiorno","year":"2024","unstructured":"Bongiorno, R. et al. Mast cell heparanase promotes breast cancer stem-like features via MUC1\/estrogen receptor axis. Cell Death Dis. 15, 709 (2024).","journal-title":"Cell Death Dis."},{"key":"991_CR45","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s43018-025-00924-3","volume":"6","author":"S Camargo","year":"2025","unstructured":"Camargo, S. et al. Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness. Nat. Cancer 6, 540\u2013558 (2025).","journal-title":"Nat. Cancer"},{"key":"991_CR46","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41590-024-01960-4","volume":"25","author":"NM Haynes","year":"2024","unstructured":"Haynes, N. M., Chadwick, T. B. & Parker, B. S. The complexity of immune evasion mechanisms throughout the metastatic cascade. Nat. Immunol. 25, 1793\u20131808 (2024).","journal-title":"Nat. Immunol."},{"key":"991_CR47","doi-asserted-by":"publisher","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. M. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. https:\/\/doi.org\/10.1002\/bjs.9736.","DOI":"10.1002\/bjs.9736"},{"key":"991_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2214\/AJR.20.25223","volume":"217","author":"DC Teichgraeber","year":"2021","unstructured":"Teichgraeber, D. C., Guirguis, M. S. & Whitman, G. J. Breast cancer staging: updates in the AJCC cancer staging manual, 8th edition, and current challenges for radiologists, from the AJR special series on cancer staging. Ajr. Am. J. Roentgenol. 217, 278\u2013290 (2021).","journal-title":"Ajr. Am. J. Roentgenol."},{"key":"991_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u2018personalized\u2019 approach to cancer staging. Cancer J. Clin. 67, 93\u201399 (2017).","journal-title":"Cancer J. Clin."},{"key":"991_CR50","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1200\/JCO.20.03613","volume":"39","author":"SM Tolaney","year":"2021","unstructured":"Tolaney, S. M. et al. updated standardized definitions for efficacy end points (STEEP) in adjuvant breast cancer clinical trials: STEEP version 2.0. J. Clin. Oncol. 39, 2720\u20132731 (2021).","journal-title":"J. Clin. Oncol."},{"key":"991_CR51","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","volume":"389","author":"S Loibl","year":"2017","unstructured":"Loibl, S. & Gianni, L. HER2-positive breast cancer. Lancet 389, 2415\u20132429 (2017).","journal-title":"Lancet"},{"key":"991_CR52","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar, W. J. et al. Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc Netw. 22, 331\u2013357 (2024).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"991_CR53","doi-asserted-by":"publisher","unstructured":"Selvaraju, R. R. et al. Grad-CAM: Visual explanations from deep networks via gradient-based localization. In Proc. 2017 IEEE International Conference on Computer Vision (ICCV) 618\u2013626 (2017). https:\/\/doi.org\/10.1109\/ICCV.2017.74.","DOI":"10.1109\/ICCV.2017.74"}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00991-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00991-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00991-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:34:50Z","timestamp":1791239690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00991-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-00991-4","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"127"}}